Key Insights

Highlights

Treatment Research

2 treatments under study, led by Expert Doubleblind Evaluation

Research Leaders

14 sponsors active, led by CRU-RISE

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Active Not Recruiting1
Enrolling By Invitation1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT05155956Active Not Recruiting

Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System

NCT07172165Enrolling By InvitationPrimary

A Multicenter Study to Optimize Microembolic Signal Classification Based on Double--Blind Multiparametric Assessment by Human Experts Using an Universal Graphical Interface [MESOMEGA]

NCT03543319Unknown

Norwegian Microemboli in Acute Stroke Study

Showing all 3 trials

Research Network

Common Treatments

  • Expert Doubleblind Evaluation1
  • Transcranial Doppler Ultrasonography Tcd1

Active Sponsors

  • CRU-RISE1
  • University of Ostrava1
  • Justus-Liebig University Gießen Medical Center1
  • Houston Methodist DeBakey Heart & Vascular Center1
  • Sound Vascular Neurology1

Top Investigators

Related Conditions

  • Ischemic Stroke1
  • Stroke1
  • Thoracic Aortic Aneurysm1
  • Thoracic Aortic Dissection1
  • Embolic Stroke1

Activity Timeline